Tools to spot, diagnose and treat cancer in women were among the products highlighted by Hologic Inc. during the 2010 RSNA show in Chicago.
The Selenia Dimensions 3-D breast tomosynthesis system addresses the primary limitations of 2-D digital mammography – the superimposition of normal breast tissue. Launched in Europe in September 2008, the system delivers both conventional digital mammogram and a tomosynthesis exam - all under one compression. The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has issued an “approvable letter” for the Selenia Dimensions system for breast tomosynthesis (3-D) imaging.
With the acquisition of Sentinelle Medical Inc., Hologic added a suite of breast magnetic resonance imaging (MRI) tools to its portfolio. Products include the Sentinelle breast MRI coil and the Sentinelle Aegis breast imaging and interventional software.
Hologic also offers alternatives to open surgical breast biopsy. The company offers the ATEC, Eviva and Celero breast biopsy devices, the Eviva upright biopsy system and ergonomically engineered MultiCare Platinum breast biopsy table. New at RSNA was a works-in-progress Abrivo breast biopsy device and Affirm breast biopsy guidance system. The Affirm stereotactic-guided biopsy device is specifically designed for the Selenia Dimensions system.
Another highlight was a display of the Aixplorer Multiwave ultrasound system. Under the terms of a new agreement, Hologic will sell, install and service SuperSonic Imagine’s Aixplorer ultrasound technology platform to the breast care community in the United States.
For more information: www.hologic.com
April 20, 2026 
